In Vitro Pharmacology of Clinically Used Central Nervous System-Active Drugs as Inverse H1 Receptor Agonists
Authors:
- M. W. NicholasMNM. W. Nicholas
- T. T. SmithTST. T. Smith
- E. S. BursteinEBE. S. Burstein
- U. HacksellUHU. Hacksell
- H. TimmermanHTH. Timmerman
- R. LeursRLR. Leurs
- M. R. BrannMBM. R. Brann
- D. M. WeinerDWD. M. Weiner
- 1 July 2007
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 322 (1) , 172-179
Abstract
The human histamine H1 receptor (H1R) is a prototypical G protein-coupled receptor and an important, well characterized target for the development of antagonists to treat allergic conditions. Many neuropsychiatric drugs are also known to potently antagonize this receptor, underlying aspects of their side effect profiles. We have used the cell-based receptor selection and amplification technology assay to further define the clinical pharmacology of the human H1R by evaluating >130 therapeutic and reference drugs for functional receptor activity. Based on this screen, we have reported on the identification of 8R-lisuride as a potent stereospecific partial H1R agonist (Mol Pharmacol65:538–549, 2004). In contrast, herein we report on a large number of varied clinical and chemical classes of drugs that are active in the central nervous system that display potent H1R inverse agonist activity. Absolute and rank order of functional potency of these clinically relevant brain-penetrating drugs may possibly be used to predict aspects of their clinical profiles, including propensity for sedation.Keywords
This publication has 41 references indexed in Scilit:
- Desloratadine Inhibits Constitutive and Histamine-Stimulated Nuclear Factor-κB Activity Consistent with Inverse Agonism at the Histamine H1 ReceptorInternational Archives of Allergy and Immunology, 2004
- 8R-Lisuride Is a Potent Stereospecific Histamine H1-Receptor Partial AgonistMolecular Pharmacology, 2004
- Synthesis and Pharmacological Identification of Neutral Histamine H1-Receptor AntagonistsJournal of Medicinal Chemistry, 2003
- New Insights into the Second Generation AntihistaminesDrugs, 2001
- Binding of antipsychotic drugs to human brain receptorsLife Sciences, 2000
- Therapeutic advantages of third generation antihistaminesExpert Opinion on Investigational Drugs, 1998
- Radioreceptor Binding Profile of the Atypical Antipsychotic OlanzapineNeuropsychopharmacology, 1996
- Constitutive activation of muscarinic receptors by the G‐protein GqFEBS Letters, 1995
- Molecular Cloning of the Human Histamine H1 Receptor GeneBiochemical and Biophysical Research Communications, 1994
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976